PRESENTATION · May 2025 · PDF
Science
Explore conditions, clinical trials, and the latest research.
These pages contain non-exhaustive scientific information about uses of products that have not yet been approved by regulatory authorities, as their efficacy and safety for these uses have not yet been established. The information is provided for educational and scientific exchange purposes, and does not suggest products should be used in a manner not consistent with their respective label approved by the regulatory authorities, which may differ by geography. Any publication reflects the state of knowledge at the time it was published. The information is not medical advice and cannot replace the independent medical judgement of a healthcare professional.
PRESENTATION · May 2025 · PDF
BBIO - Acoramidis TTR - ESC-HF 2025 - Atrial Fibrillation-related Events in Patients with ATTR-CM in ATTRibute-CM
PRESENTATION · May 2025 · PDF
BBIO - Acoramidis TTR - ESC-HF 2025 - Functional Capacity and Quality of Life in Variant ATTR-CM from ATTRibute-CM
PRESENTATION · Apr 2025 · PDF
Acoramidis TTR - ACC 2025 - Addition of Another TTR Stabilizer Did Not Further Increase Serum TTR Levels
PRESENTATION · Apr 2025 · PDF
Acoramidis TTR - ACC 2025 - Improvements in Serum TTR Levels in Variant Population
PRESENTATION · Apr 2025 · PDF